CMV Reactivation Is Rare in the Era of Biologic Therapies for Inflammatory Bowel Disease

被引：0
|
作者：
Hissong, Erika [1 ]
Yantiss, Rhonda [1 ]
机构：
[1] Weill Cornell Med Coll, New York, NY USA
来源：
LABORATORY INVESTIGATION | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
747
引用
收藏
页码：269 / 269
页数：1
相关论文
共 50 条
  • [21] Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease
    Baumgart, Daniel C.
    Le Berre, Catherine
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (14): : 1302 - 1315
  • [22] Market share and costs of biologic therapies for inflammatory bowel disease in the USA
    Yu, H.
    MacIsaac, D.
    Wong, J. J.
    Sellers, Z. M.
    Wren, A. A.
    Bensen, R.
    Kin, C.
    Park, K. T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (03) : 364 - 370
  • [23] Mucosal healing in the era of biologic agents in treatment of inflammatory bowel disease
    Florholmen, Jon
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (01) : 43 - 52
  • [24] Oral Tacrolimus for the Treatment of Refractory Inflammatory Bowel Disease in the Biologic Era
    Thin, Lena W. Y.
    Murray, Kevin
    Lawrance, Ian C.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (07) : 1490 - 1498
  • [25] Role of hospitalization for inflammatory bowel disease in the post-biologic era
    Soriano, Celine R.
    Powell, Charleston R.
    Chiorean, Michael V.
    Simianu, Vlad V.
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (26) : 7632 - 7642
  • [26] Declining Rates of Surgery for Inflammatory Bowel Disease in the Era of Biologic Therapy
    Lowe, Sarina C.
    Sauk, Jenny S.
    Limketkai, Berkeley N.
    Kwaan, Mary R.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 25 (01) : 211 - 219
  • [27] Declining Rates of Surgery for Inflammatory Bowel Disease in the Era of Biologic Therapy
    Sarina C. Lowe
    Jenny S. Sauk
    Berkeley N. Limketkai
    Mary R. Kwaan
    Journal of Gastrointestinal Surgery, 2021, 25 : 211 - 219
  • [28] Optimizing biologic therapies for inflammatory bowel disease (ulcerative colitis and crohn’s disease)
    Marc Ferrante
    Geert D’Haens
    Paul Rutgeerts
    Séverine Vermeire
    Gert Van Assche
    Current Gastroenterology Reports, 2009, 11 (6) : 504 - 508
  • [29] RISK FACTORS FOR NON-ADHERENCE TO BIOLOGIC THERAPIES IN INFLAMMATORY BOWEL DISEASE
    Wentworth, Brian J.
    Buerlein, Ross C. D.
    Nakamura, Takahiro
    Tuskey, Anne G.
    Overby, M. Ashely
    Smolkin, Mark E.
    Behm, Brian W.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S59 - S59
  • [30] Role of Biologic Therapies in the Rheumatic Manifestations of Inflammatory Bowel Disease: A Systematic Analysis
    Nag, Aiswarya
    Thomas, Jingle
    Ravichandran, Rakshana
    Gupta, Lovish
    Panjiyar, Binay K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
12345